Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Thomas F. Delaney, M.D.

Co-Author

This page shows the publications co-authored by Thomas Delaney and Joseph Schwab.
Connection Strength

3.585
  1. Definitive high-dose, proton-based radiation for unresected mobile spine and sacral chordomas. Radiother Oncol. 2022 06; 171:139-145.
    View in: PubMed
    Score: 0.243
  2. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation. Clin Orthop Relat Res. 2019 Oct; 477(10):2296-2303.
    View in: PubMed
    Score: 0.204
  3. Physical Function and Quality of Life After Resection of Mobile Spine Chondrosarcoma. Global Spine J. 2019 Oct; 9(7):743-753.
    View in: PubMed
    Score: 0.195
  4. Quality of life after resection of a chordoma of the mobile spine. Bone Joint J. 2017 Jul; 99-B(7):979-986.
    View in: PubMed
    Score: 0.174
  5. Clinical outcomes for patients after surgery and radiation therapy for mesenchymal chondrosarcomas. J Surg Oncol. 2016 Dec; 114(8):982-986.
    View in: PubMed
    Score: 0.166
  6. Updated Outcome and Analysis of Tumor Response in Mobile Spine and Sacral Chordoma Treated With Definitive High-Dose Photon/Proton Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017 02 01; 97(2):254-262.
    View in: PubMed
    Score: 0.166
  7. How Does the Level of Sacral Resection for Primary Malignant Bone Tumors Affect Physical and Mental Health, Pain, Mobility, Incontinence, and Sexual Function? Clin Orthop Relat Res. 2016 Mar; 474(3):687-96.
    View in: PubMed
    Score: 0.159
  8. Sacral Insufficiency Fractures are Common After High-dose Radiation for Sacral Chordomas Treated With or Without Surgery. Clin Orthop Relat Res. 2016 Mar; 474(3):766-72.
    View in: PubMed
    Score: 0.154
  9. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors. J Neurosurg Spine. 2015 Dec; 23(6):788-97.
    View in: PubMed
    Score: 0.154
  10. [18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine. Int J Radiat Oncol Biol Phys. 2014 Dec 01; 90(5):1030-6.
    View in: PubMed
    Score: 0.146
  11. Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas. J Surg Oncol. 2014 Aug; 110(2):115-22.
    View in: PubMed
    Score: 0.140
  12. Epithelioid hemangioma of the spine: a case series of six patients and review of the literature. Spine J. 2013 Dec; 13(12):e7-13.
    View in: PubMed
    Score: 0.134
  13. Definitive high-dose photon/proton radiotherapy for unresected mobile spine and sacral chordomas. Spine (Phila Pa 1976). 2013 Jul 01; 38(15):E930-6.
    View in: PubMed
    Score: 0.132
  14. The use of radiation therapy in the management of selected patients with atypical lipomas. Sarcoma. 2013; 2013:485483.
    View in: PubMed
    Score: 0.128
  15. Chondrosarcoma of the mobile spine: a review of 21 cases treated at a single center. Spine (Phila Pa 1976). 2012 Jan 15; 37(2):119-26.
    View in: PubMed
    Score: 0.119
  16. Low-dose neoadjuvant external beam radiation therapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2011 Jul 01; 80(3):779-86.
    View in: PubMed
    Score: 0.109
  17. Osteosarcoma of the spine: experience in 26 patients treated at the Massachusetts General Hospital. Spine J. 2010 Aug; 10(8):708-14.
    View in: PubMed
    Score: 0.108
  18. An effective preoperative three-dimensional radiotherapy target volume for extremity soft tissue sarcoma and the effect of margin width on local control. Int J Radiat Oncol Biol Phys. 2010 Jul 01; 77(3):843-50.
    View in: PubMed
    Score: 0.103
  19. Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordoma. Anticancer Res. 2009 Jun; 29(6):1867-71.
    View in: PubMed
    Score: 0.100
  20. ASO Visual Abstract: Assessing the Safety and Utility of Wound VAC Temporization of the Sarcoma or Benign Aggressive Tumor Bed Until Final Margins are Achieved. Ann Surg Oncol. 2022 04; 29(4):2302-2303.
    View in: PubMed
    Score: 0.061
  21. ASO Visual Abstract: Temporizing Wound VAC Dressing Until Final Negative Margins are Achieved Reduces Myxofibrosarcoma Local Recurrence. Ann Surg Oncol. 2021 12; 28(Suppl 3):475.
    View in: PubMed
    Score: 0.059
  22. Assessing the Safety and Utility of Wound VAC Temporization of the Sarcoma or Benign Aggressive Tumor Bed Until Final Margins Are Achieved. Ann Surg Oncol. 2022 Apr; 29(4):2290-2298.
    View in: PubMed
    Score: 0.059
  23. Temporizing Wound VAC Dressing Until Final Negative Margins are Achieved Reduces Myxofibrosarcoma Local Recurrence. Ann Surg Oncol. 2021 Dec; 28(13):9171-9176.
    View in: PubMed
    Score: 0.057
  24. Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution. Sarcoma. 2019; 2019:9069272.
    View in: PubMed
    Score: 0.052
  25. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis. Clin Orthop Relat Res. 2019 Sep; 477(9):2114-2126.
    View in: PubMed
    Score: 0.051
  26. Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST. Radiother Oncol. 2019 08; 137:61-70.
    View in: PubMed
    Score: 0.050
  27. Low dose radiotherapy is associated with local complications but not disease control in sacral chordoma. J Surg Oncol. 2019 Jun; 119(7):856-863.
    View in: PubMed
    Score: 0.049
  28. Sacral chordoma: a clinical review of 101 cases with 30-year experience in a single institution. Spine J. 2019 05; 19(5):869-879.
    View in: PubMed
    Score: 0.048
  29. Current treatment strategy for newly diagnosed chordoma of the mobile spine and sacrum: results of an international survey. J Neurosurg Spine. 2018 10 19; 30(1):119-125.
    View in: PubMed
    Score: 0.048
  30. A Phase 1 Study of Nilotinib Plus Radiation in High-Risk Chordoma. Int J Radiat Oncol Biol Phys. 2018 12 01; 102(5):1496-1504.
    View in: PubMed
    Score: 0.047
  31. Clinicopathologic characteristics of poorly differentiated chordoma. Mod Pathol. 2018 08; 31(8):1237-1245.
    View in: PubMed
    Score: 0.046
  32. High-Dose Proton Beam-Based Radiation Therapy in the Management of Extracranial Chondrosarcomas. Int J Part Ther. 2017; 3(3):373-381.
    View in: PubMed
    Score: 0.043
  33. Frequency and Risk Factors for Additional Lesions in the Axial Spine in Subjects With Chordoma: Indications for Screening. Spine (Phila Pa 1976). 2017 Jan 01; 42(1):E37-E40.
    View in: PubMed
    Score: 0.042
  34. Differences in sex distribution, anatomic location and MR imaging appearance of pediatric compared to adult chordomas. BMC Med Imaging. 2016 09 08; 16(1):53.
    View in: PubMed
    Score: 0.041
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.